IC
AMGN icon

Inscription Capital’s Amgen AMGN Stock Holding History

Inscription Capital’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$633K Buy
1,749
+349
+25% +$119K 0.06% 324
2026
Q1 		$493K Buy
1,400
+38
+3% +$13.5K 0.05% 370
2025
Q4 		$446K Buy
1,362
+640
+89% +$203K 0.05% 395
2025
Q3 		$204K Buy
+722
New +$209K 0.02% 582
2025
Q2 		– Sell
-1,225
Closed -$348K – 483
2025
Q1 		$348K Buy
+1,225
New +$362K 0.06% 225
2024
Q3 		$408K Buy
1,267
+27
+2% +$8.83K 0.06% 217
2024
Q2 		$387K Buy
1,240
+15
+1% +$4.41K 0.06% 216
2024
Q1 		$348K Buy
+1,225
New +$358K 0.06% 225
2023
Q3 		– Sell
-5,327
Closed -$1.18M – 181
2023
Q2 		$1.18M Sell
5,327
-258
-5% -$59.9K 0.37% 51
2023
Q1 		$1.35M Buy
5,585
+28
+0.5% +$6.87K 0.36% 57
2022
Q4 		$1.46M Sell
5,557
-357
-6% -$95.7K 0.5% 46
2022
Q3 		$1.33M Sell
5,914
-1,436
-20% -$348K 0.38% 46
2022
Q2 		$1.79M Buy
7,350
+801
+12% +$196K 0.32% 65
2022
Q1 		$1.58M Sell
6,549
-1,238
-16% -$284K 0.45% 54
2021
Q4 		$1.75M Buy
7,787
+765
+11% +$161K 0.48% 50
2021
Q3 		$1.49M Sell
7,022
-61,954
-90% -$14.3M 0.47% 58
2021
Q2 		$16.8M Buy
68,976
+61,389
+809% +$15.1M 1.91% 9
2021
Q1 		$1.89M Sell
7,587
-775
-9% -$185K 0.64% 44
2020
Q4 		$1.92M Sell
8,362
-341
-4% -$78.6K 0.74% 39
2020
Q3 		$2.21M Sell
8,703
-395
-4% -$97.9K 0.98% 27
2020
Q2 		$2.15M Buy
9,098
+331
+4% +$75.5K 1.19% 20
2020
Q1 		$1.78M Sell
8,767
-451
-5% -$98.5K 1.18% 24
2019
Q4 		$2.22M Buy
9,218
+1,642
+22% +$362K 0.98% 29
2019
Q3 		$1.47M Buy
+7,576
New +$1.45M 0.81% 36

Other funds holding AMGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Inscription Capital's AMGN Position: Q2 2026 in Review

Inscription Capital increased its Amgen (AMGN) stake by 25% in Q2 2026, buying an estimated $119K and bringing the position to 1,749 shares worth $633K. The position accounts for 0.06% of the portfolio, ranked #324.

Inscription Capital first reported a position in AMGN in Q3 2019 and has held it in 24 quarters since. The position peaked at $16.8M in Q2 2021. 3,158 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Inscription Capital held 1,749 shares of Amgen worth $633K as of Q2 2026.
  • Inscription Capital bought 349 Amgen shares in Q2 2026, an estimated $119K.
  • Amgen made up 0.06% of Inscription Capital's portfolio in Q2 2026, its #324 holding.
  • Inscription Capital first reported a position in Amgen in Q3 2019 and has held it in 24 quarters since.
  • Inscription Capital's Amgen position peaked at $16.8M in Q2 2021.
  • 3,158 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Inscription Capital's 13F filing for Q2 2026, filed 13 Aug 2026.